Skip to content
WorldBrand.AI

UBS Investment Bank

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    AbCellera launches $200m public offering to fund ABCL635 menopause antibody

    AbCellera Biologics launched an underwritten public offering to raise $200 million through common shares and pre-funded warrants, with net proceeds intended to support clinical advancement of its lead program ABCL635, a non-hormonal antibody for moderate-to-severe vasomotor symptoms caused by menopause.

    Source